Sohag university hospital
Sohag, Egypt
Location status: Recruiting
Location contact
Magdy M Amin, Professor
CONTACT
NCT Number: NCT07045870
this study aims to compare between effects of lidocaine and ketamine infusion on postoperative analgesia in patients undergoing thyroidectomy.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Sohag, Egypt
Location status: Recruiting
Magdy M Amin, Professor
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
group L : will receive 1.5 mg/kg bolus of iv lidocaine 10 minutes before anaesthesia induction then continuous iv infusion rate 1.5 mg / kg / h
patients will receive .25 mg / kg bolus of iv ketamine 10 minutes before anaesthesia induction then continuous iv infusion of ketamine at .25 mg /kg /h
group c will be injected with equivalent volumes and rates of .9% saline using the same application scheme as the lidocaine and ketamine as a control group
Time frame: 24 hours posftoperative
postoperative pain by Numerical Rating Scale (NRS) Zero means no pain and ten means worst pain
Contact information is provided by the study sponsor or research team.
Abdel Rahman H Abdel Rahman, Professor
CONTACT
Mario N Ishak, Resident
CONTACT
Sohag University
Other
Effects of Perioperative Intravenous Lidocaine Infusion Versus Ketamine Infusion For Postoperative Analgesia in Patients Undergoing Thyroidectomy : A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial DetailsNCT02789800
Alzheimer Disease, Alzheimer's Disease
Chicoutimi, Quebec, Canada
View Trial DetailsNCT04752969
Corneal Diseases, Corneal Opacity
Diyarbakır, Turkey (Türkiye)
View Trial DetailsNCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial Details